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Bovine neonatal pancytopenia (BNP) is a new fatal, alloimmune/alloantibody mediated disease of new-born calves
induced by ingestion of colostrum from cows, which had been vaccinated with a specific vaccine against the
Bovine Virus Diarrhoea Virus (BVDV). The hypothesis of pathogenic MHC class I molecules in the vaccine had been
put up, but no formal proof of specific causal MHC class I alleles has been provided yet. However, the unique
features of the vaccine obviously result in extremely high specific antibody titres in the vaccinated animals, but
apparently also in further molecules inducing BNP. Thus, a comprehensive picture of the immune response to the
vaccine is essential. Applying the novel approach of next generation RNA sequencing (RNAseq), our study provides
a new holistic, comprehensive analysis of the blood transcriptome regulation after vaccination with the specific
BVDV vaccine. Our RNAseq approach identified a novel cytokine-like gene in the bovine genome that is highly
upregulated after vaccination. This gene has never been described before in any other species and might be
specific to ruminant immune response. Furthermore, our data revealed a very coordinated immune response to
double-stranded (ds) RNA or a dsRNA analogue after vaccination with the inactivated single-stranded (ss) RNA
vaccine. This would suggest either a substantial contamination of the vaccine with dsRNA from host cells after virus
culture or a dsRNA analogue applied to the vaccine. The first option would highlight the potential risks associated
with virus culture on homologous cells during vaccine production; the latter option would emphasise the potential
risks associated with immune stimulating adjuvants used in vaccine production.Introduction
Vaccination regimes are a powerful strategy to protect our
animal populations against microbial diseases (e.g., [1]).
However, application of vaccination regimes requires a
comprehensive knowledge about all potential vaccin-
ation effects. Bovine neonatal pancytopenia (BNP) is a
new disease of new-born calves characterised by extreme
haemorrhages, thrombocytopenia, leukocytopenia, and cel-
lular depletion of the bone marrow [2]. BNP ends lethally
in the vast majority of cases, and no specific treatment is
available. Recent studies convincingly revealed that BNP
is an alloimmune/alloantibody mediated disease induced* Correspondence: kuehn@fbn-dummerstorf.de
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reproduction in any medium, provided the orby ingestion of colostrum from cows vaccinated with
a specific vaccine (PregSure®) against the Bovine Virus
Diarrhoea Virus (BVDV) [3-5]. This inactivated vaccine di-
rected against a single stranded (ss)RNA virus is distin-
guished by an extremely high production of specific BVDV
antibodies, which is potentially due to the unique adjuvant
included in the vaccination dose. Alloantibodies induced
after vaccination with the PregSure® BVDV vaccine bind to
MHC class I cell surface proteins of leukocytes and also of
the Madin-Darby bovine kidney (MDBK) cell line, which
had been used for production of the specific BVDV vaccine
[6,7]. Thus, the hypothesis is that contaminating MHC
class I antigens from the bovine MDBK cell line in the
vaccine act as alloantigens and elicit the production of
the pathogenic alloantibodies. However, the exact patho-
genesis of BNP is still not fully elucidated. For example,ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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much higher proportion of individuals with alloantibodies
than reported BNP cases in the population relative to the
large number of vaccinated individuals [8]. Furthermore,
no formal proof of a specific causal MHC class I allele
has been provided yet. The specific nature of the vaccine
composition can be elucidated by comprehensive know-
ledge about quantitative and structural regulation of the
blood transcriptome after vaccination with the specific
BNP-associated vaccine, which will provide novel insights
into the immune response to the vaccine.
Deep sequencing of a transcriptome by next gene-
ration RNAseq offers the tool for a precise and truly ho-
listic analysis of the expressed loci within cells and
tissues [9]. Recent studies showed that it outperforms
previous methods for transcriptome analysis due to its
large dynamic range and low technical variance [10]. In
addition, RNAseq is not restricted to the known genome
annotation but enables identification of novel, previously
unknown functionally relevant loci in the genome as re-
cently exemplified by the discovery of a novel human
interferon gene [11]. This property to add information to
an existing genome annotation is valuable especially in
genomes with no high-quality annotation like in many
livestock species including cattle.
Recently, a transcriptome analysis of peripheral blood
mononuclear cells in calves using deep sequencing re-
ported a major IFNγ/IL22 response to vaccination di-
rected against Mycobacterium bovis [12]. Furthermore,
KEGG pathways Cytokine – cytokine receptor interaction,
Cell cycle, Prion diseases and p53 signalling pathway
were significantly modulated. This demonstrates that
RNAseq experiments are a useful tool for monitoring the
immune response to vaccination.
To our knowledge, we present the first whole blood
transcriptome analysis of a livestock species in response
to a virus-based vaccine applying deep RNA sequencing.
The results provide a comprehensive catalogue of the
immune response to the specific vaccine indicating a
major reaction to RNA virus infection and an activation
of T cell response. In addition, a new cytokine-like gene
with strong protein-coding potential was identified for
the first time, which was highly upregulated after vacci-
nation, and which has not yet been described in cattle or
any other species before.
Materials and methods
Animals
All experimental procedures were carried out according
to the German animal care guidelines and were ap-
proved and supervised by the relevant authorities of the
State Mecklenburg-Vorpommern, Germany (State Office
for Agriculture, Food Safety and Fishery Mecklenburg-
Western Pommerania (LALLF M-V), 7221.3-2.1-005/11).The study included 12 lactating and non-lactating cows
aged three to five years. Except one Holstein cow, all indi-
viduals were F2 cows from a German Holstein × Charolais
crossbred population [13]. All cows were kept under the
same dairy cow conditions on the experimental farm of the
FBN Dummerstorf. All cows had received a basic double
vaccination with an inactivated BVDV vaccine (PregSure®,
Pfizer, Berlin, Germany) according to the manufacturer’s
recommendations and at least one booster vaccination 15
months prior to our experiment. Thus, the immune re-
sponse monitored in our experiment is a recall response to
a previously encountered vaccine. Four of the cows had
calves that had developed a clinical BNP. For this study,
jugular blood was taken immediately prior a further
booster vaccination with PregSure® and 14 days later.
The time point day 14 was selected due to the docu-
mented relevance of alloantibodies for BNP and because
antibody production after a PregSure® booster vaccin-
ation could be assumed to have reached a plateau at this
date [14]. After sampling, 2.5 mL blood was immediately
transferred to PAXgene blood RNA tubes (PreAnalytiX,
Hombrechtikon, Switzerland). Samples were frozen and
stored at −80 °C according to the manufacturer’s instruc-
tions until further processing.
For RT-PCR confirmation of RNAseq data regarding
XLOC_032517, tissue samples and blood samples from
four additional F2-cows from the German Holstein ×
Charolais crossbred population were analysed. All indi-
viduals had not received a vaccination with PregSure®,
but had been vaccinated with an alternative inactivated
BVDV vaccine. Tissue samples were taken immediately
after slaughter and snap frozen in liquid nitrogen and
stored at −80 °C until further processing.
Sample preparation
Whole blood RNA was isolated by the PAXgene Blood
RNA Kit (PreAnalytiX, Hombrechtikon, Switzerland)
according to the manufacturer’s instructions and stored
at −80 °C. Residual genomic DNA was carefully elimi-
nated by on-column digestion using twice the amount of
RNAse-free DNase I solution the manufacturers recom-
mended in the protocols. The samples were monitored
for RNA concentration with the NanoDrop 1000 system
(Peqlab, Erlangen, Germany). RNA integrity was de-
termined on the Bioanalyzer 2100 (Agilent, Böblingen,
Germany). Potential sample contamination with genomic
DNA was meticulously checked by PCR with genomic
primers according to [15]. Those samples showing traces
of contamination were again treated with DNAse I and
purified according to the RNAeasy Min Elute Cleanup
protocol (Qiagen, Hilden, Germany) to carefully remove
all residual DNA. Only RNA samples without detectable
DNA contamination were used for further processing in
RNAseq and locus-specific RT-PCR experiments.
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described previously [16]. Madin-Darby bovine kidney cells
(MDBK) were grown in Eagle’s Minimal Essential Medium
(EMEM) (Sigma-Aldrich Chemie, Steinheim, Germany)
supplemented with 2 mM L-glutamine (Biochrom AG,
Berlin, Germany), 1% non-essential amino acids (NEAA)
(Biochrom AG, Berlin, Germany) and 10% heat-inactivated
fetal calf serum (FCS) (PAN-Biotech GmbH, Aidenbach,
Germany). Cells were maintained at 37 °C and 5% CO2.
Total RNA was prepared from the MDBK-cells using
Trizol (Invitrogen, Darmstadt, Germany). The RNA pellet
was resuspended in 50 μL RNase-free water and stored
at −80 °C until further processing. Check for DNA con-
tamination and DNase treatment of total RNA from tis-
sues and MDBK cells were performed as described for
blood samples.
Library preparation and sequencing
RNAseq libraries were prepared from 1 μg total RNA
using the Illumina TruSeq RNA library preparation kit
(Illumina, San Diego, USA) with indexed adapter se-
quences to enable sample multiplexing during cluster
generation and sequencing by synthesis. For each indi-
vidual, two libraries were prepared: from sampling be-
fore and 14 days after vaccination resulting in a total of
24 different TruSeq RNA libraries for sequencing. The
RNAseq libraries were monitored for insert size with the
Bioanalyzer 2100 (Agilent, Böblingen, Germany) and
for highly repetitive sequences by cloning a subset of
the libraries into a plasmid vector and sequencing of
40 randomly selected clones from each library.
Taking advantage of the index adaptors, individual
mixes for each lane of the flow cells were prepared for
sequencing by pooling libraries from 12 samples for each
mix. Mixes were equally distributed on three flow cells
to avoid technical bias of results. Paired-end sequen-
cing with 2 × 61 cycles was performed on an Genome
Analyzer GAIIx (Illumina, San Diego, USA) using a PhiX
control. The resulting reads were demultiplexed using
CASAVA v1.8. All demultiplexed reads of one sample
from the different mixes and flow cells were merged into a
single fastq file and checked for quality (base quality scores,
adaptor contamination, repetitive sequences) using FastQC
[17]. The fastq files passing quality threshold served as
input for further analyses.
Sequence assembly and locus annotation
Reads were aligned to the bovine reference genome
UMD3.1 [18] using Bowtie/TopHat 2.03 [19] options.
Tophat enables spliced read alignments. For guided align-
ment options, we supplied TopHat with the bovine gene
model annotation from Igenome ([20], NCBI version, ac-
cession date 12/06/2012). The guided alignment option
employs the reference annotation in a first alignment stepusing Bowtie to map reads against a virtual transcriptome
generated from the annotation data and subsequently
converts the mapped reads to genome mapping. The
remaining reads failing to map to the virtual genome will
then be further processed for spliced alignment against the
genome. This strategy takes advantage of the existing an-
notation, but keeps also aligned reads mapping to previ-
ously unannotated transcription units of the genome.
The resulting BAM file from read alignment was fil-
tered using SAMtools [21] for reads that showed more
than two mismatches to the reference genome. Further-
more, for those reads with more than one reported align-
ment, only the alignment with the lowest query hit index
was kept to avoid multiple counting of reads during
expression analysis.
The filtered BAM file was submitted to transcript as-
sembly using Cufflinks 2.02 options [19]. Each sample
was first analysed individually for transcript assembly.
The Igenome gene annotation (see above) was provided
to guide the assembly. This enables the output of novel
genes and isoforms in addition to the provided reference
transcripts. The resulting .gtf-files containing the infor-
mation on transcript assembly for each sample were
merged using Cuffmerge with the Igenome reference an-
notation and the bovine Ensembl gene annotation re-
lease 66 [22]. This final .gtf-file was used for locus and
transcript quantification using Cuffdiff 2.02 with the bo-
vine UMD3.1 as reference genome assembly. Transcript
and locus assemblies were visualised for inspection of
the BAM files and the final annotation files with the
Integrative Genomics Viewer [23].
Differential expression analysis
The estimated number of fragments originating from
each locus in the final annotation file was obtained
using the Cuffdiff option of Cufflinks. The resulting read-
group-tracking file was filtered for the estimated fragment
count per locus for each individual and each time point.
This served as input for tests of differential expression
using edgeR [24]. In contrast to Cuffdiff, edgeR provides
the option to include systematic effects, e.g., vaccination or
animal effect in the model for differential expression by fit-
ting linear models. To test for differential locus expression,
a negative binomial distribution of read counts was as-
sumed. Only loci with an expression level exceeding 0.1
counts per million reads (cpm) in each of the 24 sam-
ples were included. After calculation of the normalisa-
tion factor, the effect of the vaccination on differential
gene expression was calculated with the model: counts =
individual + treatment. Tests for statistical significance
included accounting for multiple testing by calculating
the false discovery rate (FDR) according to [25]. Only
differences in expression with a significance threshold of
q < 0.05 were considered statistically significant.
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For pathway analysis, only loci were included with a gene
annotation and a statistically significant differential ex-
pression (q < 0.05) prior vs. after vaccination. The initial
gene annotation from the transcript assembly process in
Cufflinks was supplemented by BLAST search of se-
quences from unknown loci with the bovine NCBI Refseq
sequences (accession date 21/11/2012). The final list of
differentially expressed genes was analysed for affected
pathways using GOseq [26] and Ingenuity pathway ana-
lysis [27]. For GOseq analysis, gene acronyms were trans-
lated into Ensembl IDs using the Biomart tools [28]. Due
to the poor functional annotation of the bovine genome,
we used the human Ensembl annotation for pathway ana-
lysis in GOseq. In the GOseq analysis, the length bias
characteristic for RNAseq data is accounted for by using
the Wallenius distribution to approximate the true null
distribution. GOseq was subsequently applied to test
KEGG pathways [29] for over- or underrepresentation
in the set of differentially expressed genes. The respective
p-value for over- or underrepresentation is calculated
from the null distribution. The significant KEGG path-
way maps were inspected for significantly differentially
expressed genes.
Ingenuity pathway analysis was applied to identify bio-
logical functions, canonical pathways, networks and up-
stream regulators involved in the response to vaccination
with PregSure®. For this purpose, the list of differentially
expressed genes was investigated including the respective
logfold change to indicate the direction and quantity of diffe-
rential expression. For identification of activation or inhi-
bition of upstream regulators, a threshold for the activation
z-score calculated in the IPA analysis of |z-score| > 2
was applied.
RT-PCR confirmation of RNAseq results
The structure and expression of the novel locus XLOC_
032517 were confirmed by locus-specific RT-PCR analysis.
RNA from blood samples were investigated from all ani-
mals prior and after vaccination. In addition to individuals
vaccinated with PregSure®, expression of XLOC_032517
was monitored in blood samples from three animals of the
Charolais ×German Holstein resource population, which
had not been vaccinated with the specific BVDV vaccine.
Furthermore, also a collection of tissues from a cow of the
F2 resource population not vaccinated with the specific
BVDV vaccine and also the MKBK cell line were investi-
gated for XLOC_032517 expression.
One primer pair (TC_85490_F1/ TC_85490_R2,
Additional file 1) was designed to amplify all exons of
the XLOC_032517 transcript under the following PCR
conditions: initial denaturation at 94 °C, 35 cycles of
amplification at 62 °C annealing and 45 s for extension.
The obtained PCR fragments were excised from theagarose gel, purified using the Nucleospin Extract II kit
(Macherey and Nagel, Düren, Germany) and sequenced
on a capillary sequencer (ABI310, Life Technologies,
Darmstadt, Germany; MEGABACE 1000, GE Healthcare
Europe, Freiburg, Germany). The obtained sequences were
aligned to the sequence of XLOC_032517 as obtained by
RNAseq using Bioedit [30].
Differential quantitative expression of XLOC_032517
was confirmed by quantitative real time RT-PCR using
primers TC_85490_F3/ TC_85490_R3 essentially as de-
scribed by [15] except for cDNA synthesis performed
with oligo dT and random hexamer primers. Two refe-
rence genes (EIF3K, MTG1; Additional file 1) for nor-
malisation were obtained from the RNAseq data by
selecting loci with low normalised variance of cpm values
across all samples and with expression levels in range
with XLOC_032517. Statistical analysis of quantitative ex-
pression between time points was carried out with the SAS
MIXED procedure analogous to the analysis of the deep
sequencing data including the time point relative to vacci-
nation as fixed and the animal as random effect in the
model. Statistical analysis of differential quantitative ex-
pression between the 12 animals vaccinated with PregSure®
(sample from day 0 of our experiment) and three cows that




After demultiplexing and merging of reads, 33.1 – 45.7
million paired-end fragments (two reads per fragment)
were obtained per sample (Table 1) amounting to a total
of 953 259 252 million fragments for the entire experi-
ment. After alignment and filtering, 57.8 – 79.7 million
reads per sample (a total of 1 665 651 857 reads for the
entire experiment) were submitted to further analysis.
This dataset represented 85.1-89.0% of all reads indica-
ting a high proportion of mapped reads and a high uni-
formity between samples for both, the number of
mapped reads and also the percentage of mapped reads
relative to all reads.
Transcript annotation and quantification
Analysis of expression revealed that 28 690 loci exceeded
an expression level threshold of 0.1 cpm (counts per
million reads) in at least one sample, and 18 181 loci
exceeded this threshold in all samples. 4596 (25.3%) of
those loci with expression level > 0.1 cpm in all samples
had no previous locus annotation in the Igenome NCBI
annotation file.
The five loci with the highest cpm across all samples and
time points were serine dehydratase (SDS), ribosomal S18
RNA (RN18S1), CD74 molecule, major histocompatibility
complex (class II invariant chain, CD74), bovine major





reads with < 3 mismatches
% of reads uniquely
mapping, < 3 mismatches
% of reads mapping
to globin clusters
cow 1 before vacc Cha × GH F2 44 776 690 77 918 387 87.01 1.04
cow 1 after vacc Cha × GH F2 44 627 365 78 360 907 87.79 2.01
cow 2 before vacc Cha × GH F2 43 990 812 77 993 272 88.65 0.07
cow 2 after vacc Cha × GH F2 44 636 963 77 742 662 87.08 0.23
cow 3 before vacc Cha × GH F2 40 798 596 71 377 966 87.48 0.10
cow 3 after vacc Cha × GH F2 37 816 325 65 542 541 86.66 0.11
cow 4 before vacc Cha × GH F2 35 447 535 61 851 369 87.24 0.18
cow 4 after vacc Cha × GH F2 39 030 040 69 141 268 88.57 0.16
cow 5 before vacc GH 34 889 160 61 093 146 87.55 0.40
cow 5 after vacc GH 33 543 345 59 711 466 89.01 1.33
cow 6 before vacc Cha × GH F2 42 232 327 73 237 641 86.71 0.10
cow 6 after vacc Cha × GH F2 41 569 088 71 882 069 86.46 0.26
cow 7 before vacc Cha × GH F2 40 572 312 70 148 894 86.45 3.06
cow 7 after vacc Cha × GH F2 44 155 006 77 074 387 87.28 0.92
cow 8 before vacc Cha × GH F2 35 704 593 61 371 734 85.94 0.51
cow 8 after vacc Cha × GH F2 37 375 624 65 532 890 87.67 0.86
cow 9 before vacc Cha × GH F2 33 125 544 57 825 014 87.28 0.37
cow 9 after vacc Cha × GH F2 38 731 113 67 755 124 87.47 0.05
cow 10 before vacc Cha × GH F2 36 740 555 62 541 431 85.11 1.10
cow 10 after vacc Cha × GH F2 38 024 182 67 142 881 88.29 7.14
cow 11 before vacc Cha × GH F2 36 549 423 63 893 567 87.41 2.17
cow 11 after vacc Cha × GH F2 39 502 827 69 593 787 88.09 0.56
cow 12 before vacc Cha × GH F2 45 701 139 79 680 037 87.18 0.16
cow 12 after vacc Cha × GH F2 43 718 688 77 239 417 88.34 1.18
Total 953 259 252 1 665 651 857
Cha, Charolais; GH, German Holstein; vacc, vaccination.
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globulin (B2M), the latter three representing major deter-
minants of the histocompatibility complex in cattle.
However, it has to be considered that the cpm value does
not take transcript length into account, which results in an
up-bias of longer transcript compared to short transcripts.
Human transcriptome analysis by RNAseq is impaired
by a high proportion of reads mapping to the human
globin cluster [31]. Thus, a specific depletion of the
RNA samples for globin sequences to enhance the com-
plexity of the human RNAseq libraries is required. Initial
Sanger sequencing of individual cloned fragments from
our bovine blood RNAseq libraries identified only single
clones containing sequences with homology to the bo-
vine globin clusters (data not shown). After sequencing
the RNAseq libraries on the Illumina Genome Analyzer
GAIIx, we looked for reads mapping to the bovine α
haemoglobin cluster on BTA25 (region 190 kb – 219 kb)
or to the β haemoglobin cluster on BTA15 (region 48.990
Mb – 49.080 Mb). The percentage of reads mapping tothese chromosomal areas [0.07 to 7% of all reads (Table 1)]
is substantially lower compared to human studies (60%,
[32]) and indicates that the complexity of the bovine
RNAseq libraries is not compromised by a huge propor-
tion of reads generated from the bovine globin clusters.
Differential expression due to vaccination
Analysis of the vaccination effect on blood RNA expres-
sion yielded 2901 differentially expressed loci at a signifi-
cance threshold of q < 0.05 (Figure 1, Additional file 2).
2578 of the significantly differentially expressed loci had
an official annotation or could be identified by BLAST
search against the NCBI Refseq data set. For 323 differ-
entially expressed loci at a q < 0.05 threshold (11.1% of
all differentially expressed loci), there was no bovine gene
annotation available. Upregulation of expression after vac-
cination was observed for 1879 loci, whereas 1022 loci
showed a higher expression prior to vaccination.
Our RNAseq analyses highlighted a strong upregulation
of the previously unknown locus XLOC_032517 after
Figure 1 Annotation and differential expression of transcribed loci within the bovine blood transcriptome. All 18 181 transcripts
identified in the bovine blood transcriptome with at least 0.1 cpm in all samples were investigated. Annotated and novel (= not annotated)
transcripts are depicted regarding status of regulation after vaccination with a specific BVDV vaccine.
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032517 is on top of the list (Additional file 2) of differen-
tially expressed loci regarding statistical significance and
second regarding fold change. In spite of the very strong
regulation of XLOC_032517 expression after vaccination,Figure 2 Expression of the novel locus XLOC_032517 prior and
after vaccination. A: Number of transcripts for locus XLOC_032517
before and after vaccination in 12 cows determined by RNA seq.
cpm: counts per million reads. B: Fold change at transcript level for
locus XLOC_032517 after vaccination in 12 cows determined by
RNAseq and single-locus quantitative RT-PCR.there is no functional annotation of this locus neither in
bovine nor in any other eukaryote genome. Locus specific
RT-PCR analysis and subsequent sequencing of the
obtained product approved the sequence of the transcript.
Quantitative real-time PCR analysis confirmed a highly
significant (p < 0.0001) 3.51 fold upregulation of XLOC_
032517 expression after vaccination compared to the time
point prior vaccination (Figure 2B). XLOC_032517 tran-
scripts were also detected in blood samples of cows not
vaccinated with the PregSure® vaccine (Figure 3). Three
cows, which had never encountered PregSure® vaccination
showed a significantly lower XLOC_032517 expression
(p = 0.008) compared to the 12 cows, which had received
at least three PregSure® vaccinations. Expression analyses
of bovine tissues showed a strong XLOC_032517 expres-
sion in kidney, liver, lung, spleen and lymph node, a weak
to moderate expression in thyroid gland, skeletal muscle,
adrenal gland, brain, subcutaneous fat and mammary
gland. No expression could be detected in the pituit-
ary gland and in the MDBK cell line used for vaccine
production.
The bovine locus XLOC_032517 showed a transcript
length of 765 bp (Genbank Accession Nr. KF051797)
and comprises 4 exons on chromosome 7 (Figure 4) in
the region of 23.69 Mb between CSF2 and LOC789264.
Analysis of a potential translation of the transcript se-
quence into amino acid sequence yielded an open rea-
ding frame from nt 48 to 542. Thus, the predicted
bovine protein encoded by XLOC_032517 has 165 amino
acids and a molecular weight of 18558.56 Daltons.
Due to lack of functional annotation for XLOC_
032517 in public databases, bioinformatic analyses
searched for similarity to sequences in other species to
obtain information on the potential functional relevance
Figure 3 Expression of XLOC_032517 in blood and other bovine tissues. Detection of RT-PCR products from the XLOC_032517 locus
(A) and the reference gene EIF3K (B) in cDNA from whole blood of cows, in bovine tissue samples and the MDBK cell line. M: Molecular weight
marker, C: negative control without template, PG: pituitary gland, TG: thyroid gland, ML: skeletal muscle, KI: kidney, AD: adrenal gland, LI: liver,
LU: lung, SP: spleen, BR: brain, LN: lymph node, FA: fat, MG: mammary gland, B1: blood sample from cow vaccinated with BVDV vaccine PregSure®,
B2-B4: blood sample from cows vaccinated with an alternative BVDV vaccine, MD: MDBK cell line.
Figure 4 Structural features of the novel bovine locus XLOC_032517. A: Assignment of reads in the genomic region BTA7:23 691 000
Mb – 23 697 000 Mb visualised by Integrative Genome viewer. Annotation and orientation of the bovine CSF2 gene is indicated according to the
NCBI Btau 6.1 assembly [33]. B: Genomic structure of XLOC_032517. Boxes indicate exons (E1-E4). Solid blue colour indicates the predicted 5’and
3’UTR, shaded pattern indicates an open reading frame with the predicted coding sequence. C: Structure of the predicted XLOC_032517 protein
with signal peptide (red colour) and d2gfma motif (red dotted pattern). Significant evidence of the signal peptide motif is obtained by calculation
of S-, Y-, and C-scores with SignalP [34]. D: Homology of the predicted XLOC_032517 amino acid sequence (XLOC) with the predicted great panda
LOC100473502 amino acid sequence (AME) as determined by BLASTP [33].
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XLOC_032517 sequence detected similar genomic se-
quences in a conserved exon-intron structure (essentially
exons 1, 2, and 4) in the pig, dog, human and great panda
genomes (Additional file 3). The sequence mapped in
silico in an analogous chromosome interval flanked by
the same neighbouring genes CSF2 and P4HA2. How-
ever, in those species there was also no functional anno-
tation indicated for the respective chromosomal regions.
Further genomic sequences with partial similarity to
XLOC_032517 were found for sheep, lama, cat and horse
(either from NCBI Refseq genomes or Whole Genome
shotgun contigs deposited at NCBI). Searching the Ensembl
data base [35] for cDNAs similar to XLOC_032517 iden-
tified no strong similarity to any known cDNAs in mam-
mals. The CLTA-004 gene from human or great panda
displayed only a weak similarity (< 70% across >130 bp)
in this database. Further similarity search in the NCBI
sequence repository brought forward five functionally
non-annotated caprine sequences established by tran-
scriptome shotgun assembly from blood (e.g., Accession
Nr. JO333249.2). The identified caprine sequences showed
a high similarity to XLOC_032517 (96% identity across
713 bp). BLASTP search for similar protein sequences re-
vealed similarity only between the predicted amino acid
sequence of the bovine XLOC_032517 and a hypothetical
protein XP_002912997.1 of the LOC100473502 locus in
the great panda, which had been predicted by bioinfor-
matic analyses.
Missing functional annotation for sequences homolo-
gous to XLOC_032517 required further screening of the
XLOC_032517 transcript for potential functionally relevant
features. SignalP analysis [36] of the amino acid sequence
of the predicted protein revealed a significant indication of
a signal peptide cleavage site after amino acid (aa) 35 and a
signal peptide region comprising aa 1 to 35 (see Figure 4).
Furthermore, SMART analysis [37] indicated the additional
features IL14/IL13 (aa 14 – 123) and CSF2 (aa 36 – 158).
Although the CSF2 feature was below a significant thres-
hold, the features IL14/IL13 and CSF2 would suggest a
cytokine function of XLOC_032517, which fitted the
prediction of a signal peptide for XLOC_032517 and
also the feature SCOP: d2gmfa indicating a 4-helical cyto-
kine [38,39]. Similarity to CSF2 is also supported by the
genomic organisation of XLOC_032517, which is located
adjacent to the CSF2 – IL3 cluster of colony stimulating
factors on bovine chromosome 7 (BTA7). XLOC_032517
shares a similar four-exon structure with CSF2 and, like
CSF2 and IL3, is placed in telomere – centromere orienta-
tion on the chromosome.
Identification of differentially expressed annotated genes
Among the list of annotated differentially expressed loci
in our experiment, many groups of genes with relevancein the immune response were highlighted. Specifically,
interleukin signalling was affected indicated by differen-
tial expression of several interleukin receptor genes
(IL18R1, IL21R, IL2RA, IL7R, and IL9R). Interleukin 1
(IL1) response is promoted after vaccination due to the
upregulation of the IL1 receptor ligand IL1RL1 and the
downregulation of IL1RN (receptor antagonist) and of
IL1R2 (non-signalling receptor, q = 0.058). Furthermore,
five members of the group of suppressors of cytokine sig-
nalling are upregulated after vaccination (SOCS2, SOCS4,
SOCS5, SOCS6, SOCS7), and five ABC transporters
(ABCB8, ABCB9, ABCB10, ABCD3, ABCE1) involved in
the transport of molecules across extra- and intra-cellular
membranes and particularly important in antigen presen-
tation (ABCB8, ABCB9, [40]) were all upregulated. Up-
regulation was also observed for four genes encoding
caspases (CASP3, CASP7, CASP8, CASP8AP2). Several
chemokine receptors (CCR2, CCR4, CCR5, and CCR7)
showed significantly differential expression as did inhibi-
tors of nuclear factor of kappa light polypeptide gene en-
hancer in B cells (NFKBID, NFKBIL1, NFKBIZ). The three
STAG genes (STAG1, STAG2, and STAG3), members
of the cohesion complex [41], are all co-ordinately up-
regulated. In addition, structural maintenance of chromo-
some (SMC) condensins SMC2, SMC3, SMC4, SMC5,
SMC6 and NCAPG, a non-structural maintenance of chro-
mosomes condensin, are all higher expressed after vacci-
nation compared to prior vaccination.
Pathway analysis
Bioinformatic pathway analyses of the list of significantly
differentially expressed genes (Additional file 2) after
vaccination revealed a large number of significantly
enriched pathways, biological functions and upstream
regulators. Most of these pathways had a close associ-
ation to immune response. Our data indicated a coordi-
nated immune response to viral dsRNA sequences as
well as an upregulation of T cell response and a response
to an alloantigen.
KEGG pathways affected by vaccination
GOseq pathway analysis of differential expression re-
vealed 29 significantly over-represented KEGG pathways
(p < 0.05, Additional file 4). The Ribosome pathway stood
out as the most significantly affected pathway. Further-
more, the list of the 10 most significantly enriched KEGG
pathways also comprised Allograft rejection, Graft-versus-
host disease, Cytokine-cytokine receptor interaction, Natural
killer cell mediated cytotoxicity, and RIG-I-like receptor sig-
nalling indicating a major immune response to an alloanti-
gen and a response to an RNA virus. Other significantly
enriched KEGG pathways with an impact on immune re-
sponse were theMAPK signalling pathway, the T cell recep-
tor signalling, the Toll-like receptor signalling, the Fc epsilon
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The KEGG pathway analysis confirmed that after vac-
cination the individuals responded to a viral RNA anti-
gen due to overrepresentation of differentially expressed
genes from the RIG-I-like receptor signalling pathway
(Additional file 5) and upregulation of DDX58 encoding
RIG I, a sensor of dsRNA [42]. Furthermore, the KEGG
pathway downstream to the RIG-I-like receptor signalling,
MAPK signalling, was confirmed as significantly affected
by the vaccination in our transcriptome analysis. For the
MAPK signalling pathway, differentially expressed genes of
almost all parts of the pathway were observed.
Biological functions affected by vaccination
IPA analysis indicated that main biological functions af-
fected by vaccination (Additional file 6) can be separated
into four main groups: biological functions indicating an
activation of gene expression, biological functions related
to blood cell development and differentiation, biological
functions involved in cell death, cell cycle and survival,
and the biological function of ubiquination. Specifically,
the functions differentiation of blood cells, development
of blood cells and development of leukocytes or quantity
of T lymphocytes (Additional file 6) showed a highly sig-
nificant overrepresentation of genes. Other categories of
biological functions affected by vaccination comprise infec-
tious disease, cell mediated immune response, humoral im-
mune response, immunological disease, cellular assembly
and organisation, cellular development, cellular function
and maintenance, haematological system development and
function, lymphoid tissue structure and development, pro-
tein synthesis and posttranslational modification.
Canonical pathways affected by vaccination
A total of 178 different canonical pathways were found
significantly overrepresented as a response to vaccination
(Additional file 7) in the IPA analysis. The list included
many pathways known to be crucial during immune
response. The canonical pathways highlight two key
mechanisms in response to vaccination: response to
dsRNA or a dsRNA analogue and upregulation of T cell
receptor signalling.
In addition to the RIG I signalling pathway identified in
KEGG, IPA showed a significant enrichment of differen-
tially expressed loci for main mechanisms of protection
against RNA viral infection: EIF2 signalling and TLR3 sig-
nalling within the TLR signalling pathway. Further path-
ways related to virus infection that are significantly
enriched with differentially expressed loci are NFkB activa-
tion by viruses and virus entry via endocytic pathways.
The IPA analysis highlighted the EIF2 signalling
(Additional file 8) as the most significantly enriched
pathway seen as an effect of vaccination. In our dataset, the EIF2AK2 gene encoding PKR and EIF2A encoding
phosphorylate translation initiation factor EIF2 α are sig-
nificantly upregulated after vaccination. Also several other
kinases and translation initiation factors in the EIF2 sig-
nalling pathway showed a higher expression level after
vaccination compared to the status prior vaccination.
Within the canonical pathway Toll-like receptor signal-
ling, specifically the string starting with TLR3, is sig-
nificantly overrepresented in the list of differentially
expressed genes after vaccination (Additional file 9). The
TLR3 receptor is a specific receptor for dsRNA [43]. The
respective gene is upregulated after vaccination. Further-
more, several genes downstream in the TLR signalling
pathway that lead to transcription of proinflammatory
cytokines are also co-ordinately upregulated (IRAK4,
TAB2, MAP3K7 encoding TAK1, MAPK8 encoding
JNK1 and FOS encoding c-fos).
Besides response to dsRNA or a dsRNA analogue, the
upregulation of T cell receptor signaling is a second
major regulatory response to vaccination identified in
our data set by Goseq analysis of the KEGG database
(see above) as well as by IPA analysis of canonical path-
ways (Additional file 10). The CD3G gene encoding a
member of the T cell receptor cluster as well as ZAP70
encoding a protein kinase activated by TCR clustering
are both upregulated. In addition, all three major down-
stream signaling pathways of ZAP70 (NF-AT, Ras and
also PKC) contain several significantly upregulated mo-
lecules. Examples are PPP3CA and PPP3CB encoding
peptides belonging to the PP2B complex and the NFAT5
gene. Support for the hypothesis of a ZAP70 down-
stream regulation is also supported by the canonical
pathways role of NFAT in regulation of immune response
and PKCʘ signaling in T lymphoctes being significantly
enriched with differentially expressed genes. Upregulation
of T cell receptor signaling is also confirmed by the path-
way CD28 signaling in T helper cells being significantly
enriched with differentially expressed genes. Most of
those genes are upregulated, only MHC class II DOB is
downregulated.
In contrast to T cell activation, the IPA analysis indi-
cated a downregulation of B cell activation 14 days after
vaccination in our data: Most of the genes in the signifi-
cantly affected canonical pathway B cell development are
downregulated (Additional file 11), and key molecules at
the start points of B cell receptor signal transduction are
also downregulated. CD79A and CD79B act as signal
transducers of the B cell receptor in B cells, and both
showed a higher expression prior to vaccination com-
pared to 14 days after vaccination. Not only the initial
signal transducers CD79A/B, but also a co-stimulator
for B cell receptor signalling, CD19, is downregulated.
A further signalling receptor required for B cell activa-
tion, CD40 showed a significantly lower expression after
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of B cell development from stem cell to plasma cell are
all downregulated with the exception of IL7-R and
CD80/CD86. However, the latter molecules also appear
on the surface of non-B cell antigen presenting cells and
are not specific to the B cell lineage.
The canonical pathway NFκB signalling is significantly
enriched for differentially expressed genes after vacci-
nation. Specifically genes in the signalling cascade of NFκB
for B cell maturation are co-ordinately downregulated
(Additional file 12) adding further evidence towards
suppression of B cell maturation.
Major upstream regulators
Pathway analysis identified major upstream regulators
based on expected causal effects between upstream re-
gulators and target genes and predicts activation or in-
hibition of those regulators. Highly significantly affected
upstream regulators in our data set were v-myc mye-
locytomatosis viral related oncogene (neuroblastoma de-
rived, MYCN), the T cell receptor complex TCR, the CD40
ligand (CD40LG), CD28, E2F transcription factor 1 (E2F1),
interleukin 2 (IL2), transforming growth factor beta 1
(TGFB1), CD3, and microRNAs miR-30c-5p, miR-155-5p
and miR-124-3p (Table 2, Additional file 13).
Discussion
Our study investigated the recall response to vaccination
with the vaccine associated with BNP. The potential
relevance of a recall response to this vaccine for BNP is
underlined by data indicating that an increased fre-
quency of vaccination in an individual is associated with
increased alloantibody titres [8].
Identification of a novel locus significantly related
to immune response
Applying the holistic deep sequencing approach to the
entire bovine blood transcriptome, we identified 4596
previously unknown transcribed loci in the bovine ge-
nome. This confirms the power of the RNAseq approach
to reveal novel functional elements in immune response.
A prime example for the potential relevance of these
new functional elements is the gene XLOC_032517, a
previously unknown locus with the most significant dif-
ference of all investigated loci regarding expression re-
lated to vaccination with a specific BVDV vaccine. The
new gene could be detected in bovine blood samples of
divergent origin and also in a variety of tissues except pi-
tuitary gland. The level of expression varied between tis-
sues with those tissues showing the strongest expression,
which have a particular relevance during immune response
to invading pathogens (e.g. lymph node, spleen, and lung).
There is no annotation of the locus in any other species,
and also no transcripts with homology to XLOC_032517were identified in any database except for goat. This
might indicate that the XLOC_032517 is specific to
ruminant immune response, although a predicted pro-
tein from Ailuropoda melanoleuca (XP_002912951.1) has
a partial similarity to the predicted XLOC_032517 pro-
tein. The partially conserved exon-intron-structure of
homologous sequences in the human and other genomes
might point forward to an evolutionary process for
XLOC_032517 to become transcriptionally active or si-
lenced, respectively.
Due to lack of any previous data on XLOC_32517, its
functional role was completely unknown. Bioinformatic
search for functionally relevant structural features of
locus XLOC_032517 added further pieces of evidence
that the new gene is involved in immune response due
to its similarity with structural features identified in
CSF2 and IL14/IL13 and its predicted affiliation to the
4-helical cytokine superfamily. Studies from human indi-
cate that CSF2 is expressed in human leukocytes espe-
cially upon activation [44]. Interestingly, only for CSF1,
expression could be detected in our data set, whereas no
expression of the other genes encoding colony stimula-
ting factors (CSF2, CSF3 or IL3) was observed. This pat-
tern is in agreement with the data set from O’Loughlin
et al. [45], who performed an RNAseq experiment on
calf leukocytes before and after weaning. It has to be
evaluated, if XLOC_032517 is a bovine functional surro-
gate to CSF2. CSF2 is not expressed in bovine blood cells
in our data set, although there is a significant and co-
ordinated upregulation after vaccination of several genes
encoding proteins of a specific transcription factor com-
plex (calcineurinA-calcineurinB-Runx1: PPP3CA, PPP3CB,
RUNX1) relevant for up-regulation of CSF2 [46]. In sum-
mary, the in silico analyses advocate that the predicted pro-
tein encoded by XLOC_032517 might be a new member of
the colony stimulating factor family in cattle. Further stu-
dies will have to confirm the predicted protein coding po-
tential of XLOC_032517 and the expression pattern in
different specific leukocyte populations.
Immune response to dsRNA or a dsRNA analogue
after vaccination
The pathway analysis of the expression data from whole
blood transcriptomes highlighted a very specific immune
response to viral dsRNA or a dsRNA analogue after vac-
cination (Figure 5). KEGG as well as IPA pathway ana-
lyses confirmed that the individuals responded to virus
RNA demonstrated by overrepresentation of differentially
expressed genes from key pathways of innate recognition
of viruses: the RIG-I-like receptor signalling pathway, the
TLR/TLR3 signalling pathway, and the EIF2 signalling via
PKR [47].
The EIF2 signalling pathway is the most signifi-
cantly vaccination-affected canonical pathway according
Table 2 List of the 20 most significant upstream regulators identified as involved in gene regulation after vaccination
as determined by IPA analysis.






miR-30c-5p (and other miRNAs w/seed GUAAACA) mature microRNA Inhibited 1.75E-07 29
MYCN transcription regulator Inhibited 4.08E-07 52
TCR complex 1.02E-06 57
miR-155-5p (miRNAs w/seed UAAUGCU) mature microRNA Inhibited 1.97E-06 34
CD40LG cytokine Activated 2.06E-06 67
CD28 transmembrane receptor Inhibited 6.13E-06 62
mir-210 microRNA 1.58E-05 16
E2F1 transcription regulator Activated 8.88E-05 52
miR-124-3p (and other miRNAs w/seed AAGGCAC) mature microRNA Inhibited 1.23E-04 38
HOXA9 transcription regulator 1.33E-04 34
IL2 cytokine Activated 1.77E-04 58
CD3 complex Inhibited 4.26E-04 98
miR-291a-3p (and other miRNAs w/seed AAGUGCU) mature microRNA Inhibited 4.55E-04 18
SMARCC1 transcription regulator 7.17E-04 4
YWHAQ other 7.37E-04 5
SHOX transcription regulator 7.37E-04 5
TGFB1 growth factor Activated 7.99E-04 187
FSH complex 1.64E-03 60
TMBIM6 other 1.68E-03 6
miR-17-5p (and other miRNAs w/seed AAAGUGC) mature microRNA Inhibited 1.94E-03 10
1 For identification of activation or inhibition of upstream regulators, a threshold for the activation z-score calculated in the IPA analysis of |z-score| > 2 was applied.
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infection via PKR. The endpoint of the EIF2 signalling
pathway is the regulation of translation. The EIF2AK2
gene encoding PKR and EIF2A encoding EIF2 α are both
upregulated after vaccination. After viral contact the PKR
is activated by autophosphorylation after binding to
dsRNA [47]. The activated form of the PKR can phospho-
rylate translation initiation factor EIF2 α, which in turn
inhibits protein synthesis via suppression of protein syn-
thesis complex formation. Downregulation of protein
translation is a method of protecting the individual against
virus replication by preventing viral structural protein syn-
thesis [48]. A downregulation of translation is also con-
firmed by analysis of biological functions affected by
vaccination (Additional file 6). Phosphorylation of EIF2A
via PRK has also been shown to mediate apoptosis by in-
creasing caspase 3 [49], which is in agreement with the
CASP3 upregulation after vaccination in our data set. Fur-
ther support for the hypothesis of a downregulated protein
synthesis after vaccination is obtained from Ribosome be-
ing by far the most significantly affected KEGG pathway
after vaccination (Additional file 4). Specific analysis
of the respective genes in that pathway indicated that
the vast majority of ribosomal protein encoding genes,which showed a significantly differential expression after
vaccination, was all concordantly downregulated (e.g., 45
of the total of 46 differentially expressed RPL and RPS
genes, Additional file 2).
The second mechanism significantly affected by vac-
cination, which protects the individual specifically against
RNA viral infection, is the RIG I signalling pathway
(Figure 5) [42,50]. The gene DDX58 encoding RIG I is
upregulated (p = 0.058). RIG I acts as a cytoplasmic sensor
of viral nucleic acids [42] and induces pro-inflammatory
cytokine and interferon I expression. Posttranslational
polyubiquination of RIG I is pivotal for activation of RIG I.
We found increased ubiquitination of proteins in the list of
significantly affected biological functions (see Additional
file 6) after vaccination. Activated ubiquitination might
thus be relevant in our experiment for RNA sensor sig-
nalling in addition to its known role during proteasomal
degradation, e.g. of viral peptides for MHC class I pre-
sentation [51].
The third mechanism of protection against viral dsRNA
(Figure 5) identified in response to vaccination in our
dataset is the activation of the TLR3 signalling pathway
known to upregulate the synthesis of proinflammatory
cytokines after TLR3 activation by dsRNA [43,47].
Figure 5 Model for the coordinated response to dsRNA after vaccination with the inactivated vaccine PregSure® against ssRNA BVD
virus. Coloured boxes indicate differentially expressed genes or significantly affected pathways when comparing gene expression before and
after vaccination. Red boxes indicate intracellular sensors of dsRNA; blue boxes indicate other genes or pathways. Red arrow indicates transport of
dsRNA into the cell, the blue dotted lines indicate activation of dsRNA sensors by dsRNA, and the blue solid lines indicate other regulatory or
activating effects.
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chinery of protection against flaviviral invasion that is
upregulated after vaccination: RNA degradation (Figure 5).
The OAS1 gene is upregulated in our data set. OAS1 is
induced by α interferons and activates RNASE L by
synthesising 2’,5’-oligoadenylates (2-5As) [48]. RNASE L
degrades viral RNA and inhibits viral replication. This
mechanism can be induced by interferon type I signalling:
a respective upregulation of IFNA16, member of the anti-
viral IFNα family, was detected in our data set. Alterna-
tively, OAS1 is able to act as sensor for dsRNA directly.
Interestingly, those two Interferon-type I-induced antiviral
pathways that also act by direct recognition of dsRNA
(OAS1, PKR, [48]) are significantly affected by BVDV
vaccination in our data set. In contrast, those other
interferon-type I-induced antiviral pathways (MX1, ADAR)
not affected by vaccination, lack dsRNA sensor activity and
are exclusively dependent on IFN alpha signalling [48].Obviously the upregulation of the protection against
dsRNA is no short term effect, because significantly dif-
ferential expression could be detected 14 days after ap-
plication of the vaccine suggesting a long lasting release
of dsRNA or dsRNA analogue molecules from the injec-
tion site. The differential expression of the dsRNA sen-
sors PKR, TLR3, and DDX58 (Figure 5) and the affected
downstream pathways in response to vaccination impli-
cate that the cells monitored in the blood must have had
contact with dsRNA. One explanation might be the
roaming of cells that incorporated viral dsRNA at the in-
jection site. However, PregSure® is an inactivated vaccine
against the BVD virus, an ssRNA pestivirus belonging to
the Flaviviridae [52]. Thus, the vaccine should only contain
ssRNA. This raises the question as to the origin of the co-
ordinated viral-dsRNA-sensor upregulation in blood cells
after vaccination. Due to the inactivated virus in the vac-
cine, intracellular virus replication after infection known to
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Thus, the vaccine itself must have contained dsRNA or a
dsRNA analogue. The dsRNA or the analogue could either
originate from cellular remnants of the host cells after virus
cultivation for vaccine production or were intentionally
added to the vaccine as adjuvant. Vaccine contamination
fits the hypothesis of a massive contamination of the
PregSure® vaccine with components of the MDBK host
cells, a bovine kidney epithelial cell line, as indicated by
[53]. This massive vaccine contamination with bovine cel-
lular contaminants could also be responsible for the
massive production of alloantibodies in cows producing
BNP inducing colostrum. Alternatively, the vaccine might
have been modulated by addition of a dsRNA analogue,
e.g. polyinosinic:polycytidylic acid (poly I:C), a toll-like
receptor (TLR) agonist that mimics the immunostimulatory
properties of dsRNA, which has been suggested to improve
vaccination effects (e.g., [54]).
Coordinated regulation of groups of genes relevant
for immune response
In addition to the coordinated activation of dsRNA
response mechanisms, the concordant differential ex-
pression of several members from groups of immune -
relevant genes further indicated a coordinated regulation
of a variety of immune response components to vacci-
nation. The promoted interleukin 1 (IL1) response is one
example, It is supported by the differentially expressed
nuclear factor of kappa light polypeptide gene enhancer
in B cells inhibitors (NFKBID, NFKBIL1, NFKBIZ) that
are known to be involved in the induction of inflamma-
tory genes activated through TLR/IL1 signalling [55].
Another example for the concordant regulation of se-
veral genes from one immune-relevant family is the
upregulation of SOCS genes, which might represent a
negative feedback to interleukin receptor upregulation
according to SOCS’ known inhibitory effects on cytokine
signalling [56].
Furthermore, upregulation of members of the cohe-
sion complex and also SMC and non-SMC condensins
that are essential during mitosis suggest a promotion of
cell division.
T cell and B cell response
In our data set, we observed a coordinated upregulation
of T cell receptor signalling upon vaccination. Signal
transduction goes via CD3, and subsequently ZAP70,
which are both upregulated. ZAP70 is known to be in-
volved in protein kinase C θ and calcineurin-induced
transcriptional activity [57]. Three major downstream
signalling pathways of ZAP70 (NF-AT, NFκB and also
JUN/FOS, [58-60]) contain several significantly up-
regulated molecules. For example, in the NF-AT signalling
pathway, PPP3CA and PPP3CB belonging to the PP2Bcomplex are upregulated as well as NFAT5, encoding a fac-
tor of activated T cells important for induction of gene ex-
pression: the NFAT5 protein belongs to the group of
nuclear factors that are crucial for inducible gene transcrip-
tion during immune response [61].
There is a coordinated regulation between genes pre-
sumably acting in antigen presenting cells and genes
presumably acting in the T cell populations: the gene
CD3G encoding a protein within the T cell receptor is
upregulated after vaccination. The CD80 and CD86 genes
encoding proteins on the surface of antigen presenting
cells also show a higher expression after vaccination. The
interaction of CD80 with ligands, e.g. CD28 or CD152 is
important for T cell communication with the antigen-
presenting cells [62]. CD28 is highlighted as a major up-
stream regulator in IPA analyses. In addition, the MHC
class II gene DO also expressed in antigen presenting cells
is downregulated after vaccination. In humans, the DO
heterodimer expressed in antigen presenting cells (macro-
phages, dendritic cells) suppresses peptide loading of MHC
class II molecules by inhibiting HLA-DM [63]. Up-
regulation of CD80 and downregulation of Bola DOB in
our data set indicates an activation of antigen presenta-
tion in the antigen presenting cells after vaccination.
A potential effector mechanism after T cell activation
is the induction of apoptosis in the antigen presenting
cells via caspase: initiator caspase CASP8 and its inter-
acting protein CASPA8AP2 as well as the effector
caspases CASP3 and CASP7 are all upregulated. The
hypothesis of induced apoptosis is also supported by
the significantly affected canonical pathway mitochon-
drial dysfunction suggesting activation of the intrinsic
or mitochondrial pathway of apoptosis and by the in-
creased expression of a member of the tumor necrosis
factor (ligand) superfamily, TNFSF10 (TRAIL). TRAIL
has been shown to trigger the activation of MAPK8/JNK,
CASP8, and CASP3 [64].
The hypothesis of T cell induced apoptosis fits also the
upregulation of GZMA expression encoding granzyme
A after vaccination. Granzyme A synthesis and transmis-
sion to target cells is a mechanism of cytotoxic T cells
killing antigen presenting target cells via the intrinsic
apoptosis pathway [65]. In addition to cytotoxic T cells,
granzyme is also produced by Natural killer (NK) cells.
These cells might also contribute to the elevated tran-
script level of the GZMA gene, because there is a signifi-
cant upregulation of genes encoding NK cell lectin-like
receptors [KLRK1 and LOC100294723 (Killer cell lectin-
like receptor subfamily B member 1B allele A-like)].
Interestingly, NKG2 encoded by KLRK1 recognizes non-
classical MHC class I proteins like polymorphic MICA
and MICB produced by stressed cells [66]. MICA is a
stress-induced self-antigen frequently expressed in virus-
infected cells. This result adds further indicators for a
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the BVDV vaccine.
In contrast to T cell activation, surprisingly B cell acti-
vation 14 days after vaccination with the BVDV vaccine
seems to be suppressed. In addition to signal transducing
peptides CD79A, CD79B and CD19, also cell surface mole-
cules along the entire process of B cell development from
stem cell to plasma cell are downregulated (IgM, IgD, Mu).
Deactivation of B cells is also supported by the down-
regulation detected for TNFRSF13C. TNFRSF13C is a re-
ceptor for B cell-activating factor (BAFF), which is known
to enhance B-cell survival in vitro and is a regulator of the
peripheral B cell population [67]. The indication on sup-
pression of B cell response at transcriptome level 14 days
after vaccination is particularly unexpected, because the
vaccine is known for high production of neutralising BVD
antibodies [14]. The reason for the lack of B cell activation
at this time point is unknown. It might be speculated that
there is a negative feedback at the level of transcriptional
regulation to counteract a high B cell response prior to day
14 post vaccination.
Alloimmune response
KEGG pathway analysis indicated the allograft rejection
pathway as significantly enriched with differentially ex-
pressed genes. This would fit the hypothesis of a sub-
stantial immune response to an alloantigen from the
BVDV vaccine [3-5]. However, close examination of the
expression of key mediators of alloantigen response indi-
cated that there was no coordinated pattern of expres-
sion indicating an activation of this pathway. On the one
hand, CD80 and CD86 expressed on professional antigen
presenting cells (e.g., macrophages) are both upregulated
and MHC class II DO (inhibitor of antigen binding to
MHC, see above) is downregulated. This would suggest
an activation of alloantigen response. On the other hand,
CD40 was downregulated, but for CD40LG, one of the
major upstream regulators identified in our data set (see
Table 2), activation was predicted. CD40 is relevant for
B cell activation [68], which is important for antibody
mediated alloantigen response and also for macrophage
mediated cytotoxic alloantigen response.
Comparison to previous studies
Comparing our data with a previous study applying deep
transcriptome sequencing in cattle [12] on the immune
response to vaccination against Mycobacterium bovis
showed that there was only a limited overlap of affected
pathways between that study and our data. Only the
cytokine – cytokine receptor interaction pathway was sig-
nificantly overrepresented with differentially expressed
genes in both studies. However, it has to be considered
that Bhuju and colleagues [12] used a very different kind
of vaccine directed against an intracellular bacterialpathogen, investigated specifically PBMC leukocyte ex-
pression and used a bovine genome annotation restricted
to genes in the previous Btau4 assembly. In contrast, our
study monitored the effect of an inactivated ssRNA virus
vaccine in whole blood samples immediately stored after
collection without any preparatory manipulation. Vartanian
and colleagues [31] summarised the advantages of analy-
sing whole blood compared to specific cell fractions. In
addition, we specifically generated a comprehensive an-
notation of the bovine genome for our analysis. We did
not find any equivalent further studies of vaccination
effects of inactivated viral vaccines with deep sequen-
cing techniques of blood transcriptomes in mammals.
Whereas there are multiple studies on immune re-
sponse to anti-viral vaccination at transcriptome level
using microarrays in human, chicken, pigs or aquacul-
ture (e.g. [69]), to the author’s knowledge respective
data are missing in cattle for vaccinations similar to
our regime.Conclusions
RNAseq of blood samples is restricted to the analysis of
those transcript-carrying cells roaming in the blood stream.
Any cellular regulation involved in immune response re-
stricted to the periphery is not captured by this technique.
However, our analyses demonstrated that a comprehensive
regulation of the immune response to vaccination can be
detected by our approach.
Our data showed a very coordinated immune response
to dsRNA or a dsRNA analogue after vaccination with the
specific, inactivated BVDV vaccine associated to BNP.
This indicates a massive contamination of the vaccine,
because the vaccine is inactivated and directed against
BVDV, an ssRNA virus. Alternatively, a dsRNA mimick-
ing agent, e.g., polyinosinic:polycytidylic acid (poly I:C), a
toll-like receptor (TLR) agonist might be constituent of
the vaccine adjuvant. The vaccine used in our experiment
had been demonstrated to generate BNP-associated allo-
antibodies, which are probably directed against cellular
contaminations of the vaccine. A contamination of the
vaccine by MDBK host cell proteins has been demon-
strated [53]. However, our data did not indicate a major,
coordinated response to an alloantigen after vaccination.
Thus, in contrast to the immune response to dsRNA or
an analogue, there is no clear mechanism identified for
activated alloantigen response after vaccination with the
BVDV vaccine from our data set. However, we did ob-
serve a previously unknown locus highly upregulated
after vaccination with potential cytokine features. It will
have to be investigated in future studies, if this novel
gene is specifically related to the vaccine used in this ex-
periment and also to BNP or if it is a gene with a general
function in immune response.
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Additional file 1: List of primers used for genomic confirmation
and differential expression of the novel locus XLOC_032517. The
table lists the sequences of all primers used for confirmation of structure
and differential expression of the new locus XLOC_032517.
Additional file 2: List of differentially expressed loci prior vs. after
vaccination at a threshold of q < 0.1. The table provides a comprehensive
list of all loci showing differential expression in response to vaccination at a
significance threshold of q < 0.10. LogFC: log fold change between
expression levels prior and after vaccination, logCPM: log cpm; gene: official
locus name or previously unknown locus (= no annotat.), locus:
chromosomal position of the expressed locus.
Additional file 3: Conservation of exon-intron structure in the
human genome for a sequence homologous to XLOC_032517. The
figure provides the result from a BLAST search with the XLOC_032517
transcript (Genbank Accession No. KF051797) against all human genome
assemblies deposited at NCBI.
Additional file 4: List of significantly overrepresented KEGG
pathways established by GOseq analysis from the list of
significantly differentially expressed genes after vaccination. The
table lists all significantly affected KEGG pathways with the respective
p-values for overrepresentation of genes showing a significantly different
expression in response to vaccination.
Additional file 5: KEGG pathway RIG I like receptor signalling. The
overview of the KEGG RIG I like receptor signalling pathway indicates
significantly affected downstream KEGG pathways and differentially
expressed genes after vaccination with the PregSure® vaccine obtained
from GOseq analyses. All non-differentially expressed genes have a white
background, all upregulated genes have an orange-red background and
all downregulated genes have a green background. All differentially
expressed genes or significantly affected pathways share the red frame.
Solid red frames indicate results obtained from the KEGG data base,
dashed red frames highlight significantly affected biological functions as
indicated by IPA analysis.
Additional file 6: List of biological functions significantly affected
by vaccination as determined by IPA analysis. The folder “categories
of affected function” summarises the affected biological functions into
categories according to IPA analysis. Furthermore, the range of p values
for overrepresentation and the number of differentially expressed loci in
each category is indicated. The folder “affected_biological_functions” lists
the individual biological categories with a significant overrepresentation
of differentially expressed genes. Furthermore, the predicted activation
status and the number of differentially expressed genes assigned to the
respective function are indicated.
Additional file 7: List of canonical pathways significantly affected
by vaccination as determined by IPA analysis. The table lists all
significantly affected canonical pathways obtained by IPA analysis with the
respective p-values for overrepresentation of genes showing a significantly
different expression in response to vaccination. The ratio provides the
proportion of genes in the respective canonical pathway, which are
significantly differentially expressed after vaccination, relative to all genes in
the pathway. In addition, the proportion of upregulated and downregulated
genes in the respective pathway and a full list of all differentially expressed
genes assigned to the respective pathway are indicated.
Additional file 8: EIF2 signalling canonical pathway significantly
affected by vaccination. The figure highlights all elements within the
IPA canonical pathway EIF2 signalling differentially expressed after
vaccination. Orange/red elements: upregulated after vaccination, green
elements: downregulated after vaccination. Colour intensity reflects the
different fold change of expression.
Additional file 9: TLR signalling canonical pathway significantly
affected by vaccination. Elements within the IPA canonical pathway
TLR signalling differentially expressed after vaccination are indicated.
Orange/red elements: upregulated after vaccination, green elements:
downregulated after vaccination. Colour intensity reflects the different
fold change of expression.Additional file 10: T cell receptor signalling canonical pathway
significantly affected by vaccination. Elements within the IPA
canonical pathway T cell receptor signalling differentially expressed after
vaccination are indicated. Orange/red elements: upregulated after
vaccination, green elements: downregulated after vaccination. Colour
intensity reflects the different fold change of expression.
Additional file 11: B cell development canonical pathway
significantly affected by vaccination. Elements within the IPA
canonical pathway B cell development differentially expressed after
vaccination are indicated. Orange/red elements: upregulated after
vaccination, green elements: downregulated after vaccination. Colour
intensity reflects the different fold change of expression.
Additional file 12: NFκB signalling canonical pathway significantly
affected by vaccination. Elements within the IPA canonical pathway
NFκB signalling differentially expressed after vaccination are indicated.
Orange/red elements: upregulated after vaccination, green elements:
downregulated after vaccination. Colour intensity reflects the different
fold change of expression.
Additional file 13: List of target molecules for predicted upstream
regulators of differential expression after vaccination as determined
by IPA analysis. The file provides a list of predicted upstream regulators
obtained by IPA analysis from the data set of differentially expressed
genes. In addition, for all upstream regulators, all respective differentially
expressed target genes are indicated.
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